Literature DB >> 28361605

Development of microemulsions for ocular delivery.

Nivedita Gautam1, Karthikeyan Kesavan1.   

Abstract

Microemulsions (MEs) are thermodynamic stable dispersion of oily phase and aqueous phase stabilized by surfactants and co-surfactants, and are a small droplet size of less than 100 nm. MEs are appropriate systems for ocular drug delivery because they improve ocular drug retention, extended duration of action, high ocular absorption, permeation of loaded drugs and effortlessness of preparation and administration. This review is an effort to summarize the recent development in the area of MEs, self-emulsifying drug delivery systems, which are examined in relation to their uses in ocular drug delivery. The noteworthy patent, toxicity and stability issues related to these ME systems are also explored here.

Entities:  

Keywords:  co-surfactant; microemulsions; ocular drug delivery system; surfactant

Mesh:

Substances:

Year:  2017        PMID: 28361605     DOI: 10.4155/tde-2016-0076

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  5 in total

Review 1.  Nanocarriers for ocular drug delivery: current status and translational opportunity.

Authors:  Srividya Gorantla; Vamshi Krishna Rapalli; Tejashree Waghule; Prem Prakash Singh; Sunil Kumar Dubey; Ranendra N Saha; Gautam Singhvi
Journal:  RSC Adv       Date:  2020-07-24       Impact factor: 4.036

Review 2.  Microemulsion-Based Media in Nose-to-Brain Drug Delivery.

Authors:  Anna Froelich; Tomasz Osmałek; Barbara Jadach; Vinam Puri; Bozena Michniak-Kohn
Journal:  Pharmaceutics       Date:  2021-02-02       Impact factor: 6.321

Review 3.  Ophthalmic Nanoemulsions: From Composition to Technological Processes and Quality Control.

Authors:  Agnieszka Gawin-Mikołajewicz; Karol P Nartowski; Aleksandra J Dyba; Anna M Gołkowska; Katarzyna Malec; Bożena Karolewicz
Journal:  Mol Pharm       Date:  2021-09-17       Impact factor: 4.939

4.  Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents.

Authors:  Sergio Esteban-Pérez; Vanessa Andrés-Guerrero; José Javier López-Cano; Irene Molina-Martínez; Rocio Herrero-Vanrell; Irene Bravo-Osuna
Journal:  Pharmaceutics       Date:  2020-03-28       Impact factor: 6.321

Review 5.  Lipid-Based Nanocarriers as Topical Drug Delivery Systems for Intraocular Diseases.

Authors:  Jose Navarro-Partida; Carlos Rodrigo Castro-Castaneda; Francisco J Santa Cruz-Pavlovich; Luis Abraham Aceves-Franco; Tomer Ori Guy; Arturo Santos
Journal:  Pharmaceutics       Date:  2021-05-09       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.